Literature DB >> 4026785

Platelet depletion in experimental myocardial infarction.

S R Jolly, W A Schumacher, S L Kunkel, G D Abrams, J Liddicoat, B R Lucchesi.   

Abstract

Accumulation of platelets in the microvasculature after acute myocardial ischemia may exacerbate tissue injury through the formation of microthrombi and by the release of vasoactive substances. To assess the role of platelets in myocardial ischemic injury and infarction, circulating platelets were reduced by 94 +/- 2% (mean +/- S.E.M.) with sheep antiserum to canine platelets. Regional myocardial ischemia was produced by occlusion of the left circumflex coronary artery (LCCA) for 90 min followed by reperfusion for 5 hours. Infarct size did not differ significantly between antiplatelet serum and nonimmune serum groups: 36 +/- 8 vs. 43 +/- 4% of the area at risk, determined by a post-mortem dual staining technique (p greater than 0.05). A second occlusion-reperfusion control group, sacrificed at 24 hours, did not differ from 5 hr reperfused groups with regard to infarct size. Coronary sinus thromboxane B2 (TXB2) concentrations were not altered significantly by platelet depletion. Histopathologic examination confirmed the presence of necrosis in the infarcted myocardium and revealed substantial leukocytic infiltration in both groups. The results suggest that circulating platelets are not required for the full expression of myocardial ischemic injury resulting from temporary coronary artery occlusion followed by reperfusion.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4026785     DOI: 10.1007/bf01907903

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  31 in total

1.  A radioimmunoassay for thromboxane B2.

Authors:  F A Fitzpatrick; R R Gorman; J C Mc Guire; R C Kelly; M A Wynalda; F F Sun
Journal:  Anal Biochem       Date:  1977-09       Impact factor: 3.365

2.  Adenosine diphosphate-induced platelet aggregation and myocardial infarction in swine.

Authors:  L Jorgensen; H C Rowsell; T Hovig; M F Glynn; J F Mustard
Journal:  Lab Invest       Date:  1967-12       Impact factor: 5.662

3.  Isolation of membranes from normal and thrombin-treated gel-filtered platelets using a lectin marker.

Authors:  S Rittenhouse-Simmons; D Deykin
Journal:  Biochim Biophys Acta       Date:  1976-04-05

4.  Endothelial healing following defined injury to rabbit aorta. Depth of injury and mode of repair.

Authors:  L N Walker; M M Ramsay; D E Bowyer
Journal:  Atherosclerosis       Date:  1983-05       Impact factor: 5.162

5.  Potential effect of lidocaine on ischemic myocardial injury: experimental and clinical observations.

Authors:  H Boudoulas; P E Karayannacos; R P Lewis; G S Kakos; J W Kilman; J S Vasko
Journal:  J Surg Res       Date:  1978-06       Impact factor: 2.192

6.  The beneficial effects of oral ibuprofen on coronary artery thrombosis and myocardial ischemia in the conscious dog.

Authors:  J L Romson; L R Bush; D W Haack; B R Lucchesi
Journal:  J Pharmacol Exp Ther       Date:  1980-10       Impact factor: 4.030

7.  Ischemic changes in the canine heart as affected by the dimethyl quaternary analog of propranolol, UM-272 (SC-27761).

Authors:  B R Lucchesi; W E Burmeister; T E Lomas; G D Abrams
Journal:  J Pharmacol Exp Ther       Date:  1976-11       Impact factor: 4.030

8.  Relation of microcirculatory thrombosis to thrombus in the proximal coronary artery: effect of aspirin, dipyridamole, and thrombolysis.

Authors:  C B Moschos; K Lahiri; M Lyons; A B Weisse; H A Oldewurtel; T J Regan
Journal:  Am Heart J       Date:  1973-07       Impact factor: 4.749

9.  Streptokinase thrombolysis in experimental coronary artery thrombosis: pattern of reflow and effect of a stenosis.

Authors:  W A Schumacher; A J Buda; B R Lucchesi
Journal:  Int J Cardiol       Date:  1984-11       Impact factor: 4.164

10.  Lack of thromboxane A2 involvement in the arrhythmias occurring during acute myocardial ischemia in dogs.

Authors:  S E Burke; M J Antonaccio; A M Lefer
Journal:  Basic Res Cardiol       Date:  1982 Jul-Aug       Impact factor: 17.165

View more
  6 in total

1.  The cardioprotective effects of the thromboxane receptor antagonist SQ 30,741 are not reversed by aspirin.

Authors:  G J Grover; C S Parham; W A Schumacher
Journal:  Basic Res Cardiol       Date:  1991 Mar-Apr       Impact factor: 17.165

Review 2.  Protease-activated receptors and myocardial infarction.

Authors:  Silvio Antoniak; Rafal Pawlinski; Nigel Mackman
Journal:  IUBMB Life       Date:  2011-03-24       Impact factor: 3.885

3.  Platelet-Mediated Transfer of Cardioprotection by Remote Ischemic Conditioning and Its Abrogation by Aspirin But Not by Ticagrelor.

Authors:  Helmut Raphael Lieder; Maria Tsoumani; Ioanna Andreadou; Karsten Schrör; Gerd Heusch; Petra Kleinbongard
Journal:  Cardiovasc Drugs Ther       Date:  2022-05-21       Impact factor: 3.947

4.  Effects of iloprost, a PGI2 derivative, on ischemic myocardial energy and carbohydrate metabolism in dogs.

Authors:  K Ichihara; K Yamamoto; Y Abiko
Journal:  Mol Cell Biochem       Date:  1993-02-17       Impact factor: 3.396

5.  In vivo neutralization of P-selectin protects feline heart and endothelium in myocardial ischemia and reperfusion injury.

Authors:  A S Weyrich; X Y Ma; D J Lefer; K H Albertine; A M Lefer
Journal:  J Clin Invest       Date:  1993-06       Impact factor: 14.808

Review 6.  Pathophysiology of myocardial ischemia: importance of platelet-vessel wall interactions.

Authors:  J R Parratt
Journal:  Cardiovasc Drugs Ther       Date:  1988-05       Impact factor: 3.727

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.